UnitedHealth Group (UNH, Financial) has received renewed attention as JP Morgan analyst Lisa Gill made key updates to the stock's price target and rating. On June 20, 2025, it was reported that the price target for UNH has been raised from $405.00 to $418.00, which marks a 3.21% increase.
Despite the adjustments in price target, JP Morgan maintains their "Overweight" rating for UnitedHealth Group (UNH, Financial). This consistent rating underscores a positive outlook for the company's stock performance, according to analyst insights.
The updated price target and maintained rating suggest that UnitedHealth Group (UNH, Financial) remains a strong candidate for investment consideration in the healthcare sector, as highlighted by JP Morgan's recent assessment.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 24 analysts, the average target price for UnitedHealth Group Inc (UNH, Financial) is $380.92 with a high estimate of $677.00 and a low estimate of $270.00. The average target implies an upside of 24.00% from the current price of $307.20. More detailed estimate data can be found on the UnitedHealth Group Inc (UNH) Forecast page.
Based on the consensus recommendation from 28 brokerage firms, UnitedHealth Group Inc's (UNH, Financial) average brokerage recommendation is currently 2.2, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for UnitedHealth Group Inc (UNH, Financial) in one year is $703.71, suggesting a upside of 129.07% from the current price of $307.2. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the UnitedHealth Group Inc (UNH) Summary page.
